Evidence map›Paper›PMID 41832397›Full record

ReviewCell biology and toxicology2026

RNA m

Qingjuan Chen, Hongzhao Lu, Dezhi Li, Tao Liu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cell biology and toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qingjuan Chen *Department of Oncology, 3201 Hospital, Hanzhong, China. dr.qingjuan.chen@outlook.com.
Hongzhao Lu *College of Biological Science and Engineering, Shaanxi University of Technology, Hanzhong, 723000, China.
Dezhi LiDepartment of Oncology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, China.
Tao LiuUniversity of New South Wales, New South Wales, Sydney, NSW, 2052, Australia.

Funding

Genertec Medical Research Fund TYYLKYJJ-2023-011Natural Science Basic Research Program of Shaanxi Province 2024JC-YBMS-756
6 · The paper itself

Abstract

N6-methyladenosine (m

Indexed as

AdenosineStomach NeoplasmsAnimalsEpitranscriptomeGene Expression Regulation, NeoplasticHumansRNA MethylationAdenosineN-methyladenosineCancer therapyDrug resistanceGastric cancerM6A methylationM6A regulatorsTumorigenesis

Identifiers

PMID41832397
PMCPMC13102813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.